Capital Research Global Investors
LHDX

Capital Research Global Investors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Capital Research Global Investors’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,115,416
Closed -$13.5M – 457
2021
Q1 		$13.5M Buy
+1,115,416
New +$22.1M ﹤0.01% 402

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JCM
JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Capital Research Global Investors's LHDX Position: Q2 2021 in Review

Capital Research Global Investors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 1,115,416 shares — an estimated $13.5M sold.

Capital Research Global Investors first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $13.5M in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

  • Capital Research Global Investors reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Capital Research Global Investors sold 1,115,416 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $13.5M.
  • Capital Research Global Investors first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Capital Research Global Investors's Lucira Health, Inc. Common Stock position peaked at $13.5M in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on Capital Research Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.